223 related articles for article (PubMed ID: 35224096)
1. Current Status of Malignant Tumors after Organ Transplantation.
Shen B; Cen Z; Tan M; Song C; Wu X; Wang J; Huang M
Biomed Res Int; 2022; 2022():5852451. PubMed ID: 35224096
[TBL] [Abstract][Full Text] [Related]
2. Abdominal computed tomography findings of malignant tumors in patients with solid organ transplants.
Ulu EM; Tutar NU; Coskun M; Tore HG; Guvenc Z; Haberal M
Transplant Proc; 2007 May; 39(4):1066-70. PubMed ID: 17524893
[TBL] [Abstract][Full Text] [Related]
3. De novo malignances in pediatric organ transplant recipients.
Penn I
Pediatr Transplant; 1998 Feb; 2(1):56-63. PubMed ID: 10084762
[TBL] [Abstract][Full Text] [Related]
4. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V
Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661
[TBL] [Abstract][Full Text] [Related]
5. Review of Standardized Incidence Ratios (SIR) of non-lymphoid de novo malignancies after liver transplantation: Structured analysis of global differences.
Patel JA; Daoud D; Jain A
Transplant Rev (Orlando); 2022 Jan; 36(1):100670. PubMed ID: 34688986
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review.
Gutierrez-Dalmau A; Campistol JM
Drugs; 2007; 67(8):1167-98. PubMed ID: 17521218
[TBL] [Abstract][Full Text] [Related]
7. De novo tumors after kidney transplantation: the Budapest experience.
Langer RM; Járay J; Tóth A; Hídvégi M; Végsö G; Perner F
Transplant Proc; 2003 Jun; 35(4):1396-8. PubMed ID: 12826170
[TBL] [Abstract][Full Text] [Related]
8. Malignancy after renal transplantation in the new era of immunosuppression.
Watorek E; Boratynska M; Smolska D; Patrzalek D; Klinger M
Ann Transplant; 2011; 16(2):14-8. PubMed ID: 21716180
[TBL] [Abstract][Full Text] [Related]
9.
Manzia TM; Angelico R; Gazia C; Lenci I; Milana M; Ademoyero OT; Pedini D; Toti L; Spada M; Tisone G; Baiocchi L
World J Gastroenterol; 2019 Sep; 25(35):5356-5375. PubMed ID: 31558879
[TBL] [Abstract][Full Text] [Related]
10. [Occurrence, diagnosis and treatment of de novo gastrointestinal malignancies after organ transplantation].
Ji L; Zhao G
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Oct; 20(10):1206-1210. PubMed ID: 29130236
[TBL] [Abstract][Full Text] [Related]
11. Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data.
Jain AB; Yee LD; Nalesnik MA; Youk A; Marsh G; Reyes J; Zak M; Rakela J; Irish W; Fung JJ
Transplantation; 1998 Nov; 66(9):1193-200. PubMed ID: 9825817
[TBL] [Abstract][Full Text] [Related]
12. Urological malignancy as a complication of renal transplantation: a report of twelve clinical cases.
Zhou M; Zhu Y; Wang L; Wang Y; Fu S; Min Z
Clin Transpl; 2006; ():395-8. PubMed ID: 18365395
[TBL] [Abstract][Full Text] [Related]
13. National survey of de novo malignancy after solid organ transplantation in Japan.
Miyazaki T; Sato S; Kondo T; Kusaka M; Gotoh M; Saiki Y; Ono M; Kokudo N; Enosawa S; Satoh S; Soeda E; Furukawa H; Kobayashi E; Nagayasu T
Surg Today; 2018 Jun; 48(6):618-624. PubMed ID: 29380136
[TBL] [Abstract][Full Text] [Related]
14. De Novo Malignancies After Liver Transplantation With 14 Cases at a Single Center.
Liu ZN; Wang WT; Yan LN;
Transplant Proc; 2015 Oct; 47(8):2483-7. PubMed ID: 26518956
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of de novo malignancies after solid-organ transplantation: immunosuppression, infection and other risk factors.
Piselli P; Verdirosi D; Cimaglia C; Busnach G; Fratino L; Ettorre GM; De Paoli P; Citterio F; Serraino D
Best Pract Res Clin Obstet Gynaecol; 2014 Nov; 28(8):1251-65. PubMed ID: 25209964
[TBL] [Abstract][Full Text] [Related]
16. Impact of cyclosporine versus tacrolimus on the incidence of de novo malignancy following liver transplantation: a single center experience with 609 patients.
Wimmer CD; Angele MK; Schwarz B; Pratschke S; Rentsch M; Khandoga A; Guba M; Jauch KW; Bruns C; Graeb C
Transpl Int; 2013 Oct; 26(10):999-1006. PubMed ID: 23952102
[TBL] [Abstract][Full Text] [Related]
17. Dermatological Complications After Solid Organ Transplantation.
Naldi L; Venturuzzo A; Invernizzi P
Clin Rev Allergy Immunol; 2018 Feb; 54(1):185-212. PubMed ID: 29177692
[TBL] [Abstract][Full Text] [Related]
18. Postrenal transplant malignancy: Incidence, risk factors, and prognosis.
Elserwy NA; Lotfy EE; Fouda MA; Mahmoud MI; Donia AF; Mashaly ME; Abbas MH; Abuelmagd MM; Abouelenein RK; Ismail MI; Bakr MA
Saudi J Kidney Dis Transpl; 2017; 28(3):579-588. PubMed ID: 28540896
[TBL] [Abstract][Full Text] [Related]
19. Malignancy after solid organ transplantation: an overview.
Zafar SY; Howell DN; Gockerman JP
Oncologist; 2008 Jul; 13(7):769-78. PubMed ID: 18614590
[TBL] [Abstract][Full Text] [Related]
20. Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology.
Valantine H
J Heart Lung Transplant; 2007 Jun; 26(6):557-64. PubMed ID: 17543777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]